首页>
外国专利>
Improved transdermal therapeutic system for the treatment of Parkinson's Disease
Improved transdermal therapeutic system for the treatment of Parkinson's Disease
展开▼
机译:改良的经皮治疗系统,用于治疗帕金森氏病
展开▼
页面导航
摘要
著录项
相似文献
摘要
This invention provides the use of a silicone-based transdermal therapeutic system having an area of 10 to 40 cm2 and containing 0.1 to 3.15 mg / cm2 of Rotigotine as active ingredient, for the preparation of an anti-Parkinson medicament which effects an improvement, compared to a placebo treatment, of the condition of human Parkinson patients, measured according to the Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III, of 2 units or more following administration for a time period of at least 7 weeks.
展开▼
机译:本发明提供了面积为10至40cm 2 Sup>且含有0.1至3.15mg / cm 2 Sup>罗替戈汀作为有效成分的基于硅酮的透皮治疗系统的用途。 ,用于制备抗帕金森氏病药物,与安慰剂治疗相比,该药物能改善帕金森氏病患者的病情,根据统一的帕金森氏病评定量表(UPDRS)第II部分和第III部分测量,单位为2个单位或给药后至少持续7周。
展开▼